Kara Cannon - Mar 24, 2022 Form 3 Insider Report for ENZO BIOCHEM INC (ENZ)

Role
Chief Operating Officer
Signature
/s/ Kara Cannon
Stock symbol
ENZ
Transactions as of
Mar 24, 2022
Transactions value $
$0
Form type
3
Date filed
3/28/2022, 06:00 PM
Next filing
Jul 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ENZ Common Stock, $0.01 Par Value 22.6K Mar 24, 2022 401k

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ENZ Stock Option (to acquire Common Stock) Mar 24, 2022 Common Stock 87.5K $3.36 Direct F1
holding ENZ Stock Option (to acquire Common Stock) Mar 24, 2022 Common Stock 55.4K $2.63 Direct F1
holding ENZ Stock Option (to acquire Common Stock) Mar 24, 2022 Common Stock 55.4K $2.20 Direct F1
holding ENZ Stock Option (to acquire Common Stock) Mar 24, 2022 Common Stock 52K $2.80 Direct F1
holding ENZ Stock Option (to acquire Common Stock) Mar 24, 2022 Common Stock 35K $4.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options have a five-year term and will vest in three equal installments, one on the first anniversary of the grant date, the second on the second anniversary of the grant date and the third on the third anniversary of the grant date.